Document is current

Article History

First Online: 17 July 2020

Compliance with Ethical Standards

:

: No funding was utilized in the preparation of this manuscript.

: RMZ received a travel grant from Lilly. RP has nothing to declare. JBM has served on advisory boards for Aegerion, Bayer, Boehringer Ingelheim, Lilly, Metavant, and Novo Nordisk; has consulted for Boehringer Ingelheim, Dexcom, and Valeritas; has served on speakers’ bureaus for Aegerion, Dexcom, and Janssen, and has been the principal investigator of studies sponsored by Dexcom, Medtronic, Novo Nordisk, and Sanofi.